Physician

Mojeed Akintayo, M.D.

According to 2025 Medicare claims, Mojeed Akintayo, M.D. (NPI: 1093936676) practices neuropsychiatry in the Greensboro-High Point, NC market, with the plurality of this provider's patient population coming from Guilford, NC. This provider's primary affiliated billing organization is NEUROPSYCHIATRIC CARE CENTER, PLLC (NPI: 1497098420; TIN: 461984041) and primary practice location at 27455-2596. Akintayo is affiliated with the Triad HealthCare Network, LLC. (ACO ID: D0209), participating under the REACH model.

Akintayo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 132 traditional Medicare patients, billed 546 HCPCS/CPT codes, and received $41,836 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 6,103 prescription claims across 248 beneficiaries totaling $1,001,649 in drug costs, led by Ingrezza (Valbenazine Tosylate). Open Payments data shows 16 records totaling $309. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $51,707 and ending at $41,836. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $125,377 to $1,001,649. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	213	796	$51,707
2016	310	852	$56,397
2017	241	550	$35,422
2018	246	712	$50,275
2019	222	600	$40,714
2020	198	662	$43,983
2021	179	736	$56,213
2022	183	704	$51,969
2023	158	584	$39,325
2024	132	546	$41,836

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	101	1,644	$125,377
2016	116	2,176	$157,612
2017	152	2,690	$198,839
2018	170	3,209	$278,734
2019	197	4,429	$454,242
2020	228	5,351	$715,350
2021	223	5,857	$825,379
2022	274	6,904	$1,072,276
2023	267	6,485	$1,074,919
2024	248	6,103	$1,001,649

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	18	18	$136
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	14	16	$118
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	112	414	$76
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	12	86	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ingrezza	Valbenazine Tosylate	35	1,044	$281,738
Invega Sustenna	Paliperidone Palmitate	81	2,301	$219,239
Abilify Maintena	Aripiprazole	29	828	$83,908
Perseris	Risperidone	16	455	$40,851
Fanapt	Iloperidone	12	365	$37,926

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$309	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mojeed Akintayo, M.D.?

Tedicare shows public-source Medicare data for Mojeed Akintayo, M.D. (NPI 1093936676), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mojeed Akintayo, M.D. have ACO affiliation data?

Mojeed Akintayo, M.D. is shown with ACO affiliation data for Triad HealthCare Network, LLC. (REACH, ACO ID D0209).

What billing organization is linked to Mojeed Akintayo, M.D.?

Mojeed Akintayo, M.D. is linked to NEUROPSYCHIATRIC CARE CENTER, PLLC (billing NPI 1497098420) in the available physician profile data.

Does Mojeed Akintayo, M.D. have Open Payments data?

Mojeed Akintayo, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.